Prostate cancer gene therapy

Australasian Biotechnology

Volumn 8, Issue 2, 1998, Pages 99-105

  Russell, P J ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CANCER CELL; CELL DEATH; CYTOKINE; ENZYME DIRECTED PRODRUG THERAPY; ESCHERICHIA COLI; GANCICLOVIR; GENE THERAPY; MUTATION; PROSTATE; PURINE NUCLEOSIDE PHOSPHORYLASE; THYMIDINE KINASE; TUMOR REGRESSION; TUMOR SUPPRESSOR GENE; UNITED STATES OF AMERICA;

EID: 0031870526     PISSN: 10367128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Asgari, K., Sesterhenn, I. A., McLeod, D. G., Cowan, K., Moul, J. W., Seth, P. and Srivastava, S. (1997) Inhibition of the growth of pre-established subcutaneous tumor nodules of human prostate cancer cells by single injection of the recombinant adenovirus p53 expression vector Int. J. Cancer, 71, 377-382.
2. Berges, R. R., Vukanovic, J., Epstein, J. I., CarMichel, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C. and Isaacs, J. T. (1995) Implication of cell kinetic changes during progression of human prostatic cancer Clin. Cancer Res., 1, 473-480.